Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

More melanoblasts in hair follicles mean better survival and proper hair pigmentation.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Testosterone's effects on COVID-19 are unclear and need more research.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

TLR4 is important in aging-related diseases and could be a new treatment target.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Bmpr2 and Acvr2a receptors are crucial for hair retention and color.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

The exact causes of baldness are not fully understood, limiting treatment options.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

The research identifies genes linked to wool quality in sheep and provides insights to improve wool production.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Low testosterone levels may lead to more severe COVID-19 outcomes.

The document discussed hair loss causes and treatments but didn't give a final summary.

The treatment led to denser, thicker hair growth and less hair loss.